Give your Company an important competitive advantage in the Health and Wellness Industry

Marketing Directors, Brand Managers, and Agency Creative Directors, have a powerful way to showcase Health and Wellness Products to a select group of Consumers.

It is quite rare to have such an opportunity to showcase advanced technology products to such a knowledgeable, sophisticated consumer base all in one place for 4 short days.”

— Bill Faloon, Publisher, Life Extension Magazine

BEVERLY HILLS, CA, UNITED STATES, January 19, 2019 /EINPresswire.com/ — Looking for a Competitive edge in selling to the Health and Wellness industry ?

Sharp industry leaders look to RAADfest 2019 to peek into the future of the Anti-aging product revolution.

RAADfest 2019 is the largest, most prestigious conference on reverse aging and super life extension on the planet.

Thousands of America’s most sophisticated health and wellness consumers will meet in Las Vegas October 3-6, 2019 to listen to the countries foremost scientists share their research findings on the latest products and services promising to deliver the Fountain of Youth to today's very sophisticated Wellness Consumers.

At RAADfest they will learn, network, share valuable information on the latest products and services being offered to effectively slow aging and extend their lives. Serious, sophisticated consumers committed to spending thousands of dollars annually in this most lucrative product category.

Almost every nutrient known to be beneficial to man will be represented at RAADfest 2019.

With RAADfest heading into its 4th year; A solid attendee base has been established that allows you to peek into the future of anti-aging and learn from these extraordinary people in attendance….those elusive early adopters so critical to a Companies success in the product life cycle. See just how much money these motivated individuals are willing to spend to stay healthy and youthful in their 50’s, 60’s and even their 80’s.

Ask yourself, Why spend $10,000 on a 24 person focus group when you or your clients company can actually meet, query, product test, sell new product, secretly observe and even video thousands of some of the most sophisticated consumers on anti-aging products in America choose their health products and wellness services.

Imagine shooting a TV commercial or a product video with this opening line…
” Your company here at the world’s largest most prestigious conference on anti-aging showcasing our latest product to make you look and feel young again”…..We are testing our latest most advanced scientifically proven product to some of the most sophisticated consumers in America. Let’s see what they have to say about this .….”

RAADfest will set the stage for you. All you need is your sharpest marketing and creative people to attend. Your client showcases their latest products; You can even have your companies science team speak on the RAADcity Stage presenting scientific research supporting your unique product advantages for peer review.

A nice financial benefit to exhibiting… RAADfest allows product sales to the thousands in attendance. A special group of highly respected product innovators from all over the world.

National one-of-a kind conventions like RAADfest 2019 are a great way to bring together the best scientific minds to share valuable information on product innovation. A great opportunity to inexpensively test the latest product developments, to get a real feel for how your target audience will respond to your advertising message and your unique product benefits.

Your client can exhibit, price test and sell product. Or, they can sponsor a specialty category, speak, shoot commercials, product quality test, conduct consumer research and whatever other creative suggestions you share with us is open for discussion. You are only limited by your Creativity.

RAADfest is all about scientific breakthroughs in anti-aging and healthy life extension. If your client’s product is that relevant then we want to share it with our motivated attendees and will price our sponsorships very reasonably to allow you to test the power of attracting this extraordinary loyal audience RAADfest generates. This year to encourage Agency participation, RAADfest will be agency commissionable, making everyone involved a financial participant in this amazing one-of kind event.

As Life Extension Magazine Publisher William Faloon so elegantly states, “ it is quite rare to have such an opportunity to showcase advanced technology products to such a knowledgeable, sophisticated consumer base all in one place for 4 short days. It is like having a miniature scale product launch without all the cost and risk associated with an actual launch". RAADfest is a unique target rich audience with deep pockets and a thorough knowledge of anti-aging health and wellness products.

RAADfest welcomes all products and services in the Health and Wellness field.
To learn more about RAADfest 2019 please visit our dedicated website @ www.RAADfest.com or contact Vincent Stona @ 727-726-4746

';[

Vincent Stona
Anti-aging Educational Foundation
+1 727-726-4746
email us here


Source: EIN Presswire

Pollock Clinics Now Offers Erectile Dysfunction Treatments in Vancouver

erectile dysfunction causes and cures

p shot pricing vancouver

erectile dysfunction dr

Men's Sexual Health Program Focused on ED Treatment for BC Men

VANCOUVER, BRITISH COLUMBIA, CANADA, January 18, 2019 /EINPresswire.com/ — Pollock Clinics is proud to announce the addition of a Men’s Sexual Health and Wellness Program focused on the treatment of erectile dysfunction (ED).

Pollock Clinics approaches the diagnosis of erectile dysfunction by conducting a comprehensive initial assessment. A personalized treatment plan can then be developed based on your specific circumstances.

The initial consultation and assessment are covered by MSP of BC with a doctor’s referral.

Erectile Dysfunction – Causes & Solutions

The Canadian Study of Erectile Dysfunction identified that 49.4% of men over 40 have some experience with ED (from the Canadian Urological Association erectile dysfunction guideline 2015). Though all men may experience an occasional lapse of sexual function, ED is the persistent inability to achieve an erection, despite being sexually aroused. Erectile dysfunction is a potentially treatable medical condition that is not related to masculinity or sexual prowess.

At Pollock Clinics, they are dedicated to providing our patients with the latest innovative treatments to erectile dysfunction. The men’s sexual health program focuses on erectile dysfunction treatments and any associated issue with low testosterone.

Vancouver ED Treatments & Services

Pollock Clinics offers both physiological and psychological treatments for erectile dysfunction. Options include:

Erectile Dysfunction Shockwave Therapy (EDSWT)

The application of low-intensity shockwaves (like sound waves) to help re-establish proper blood flow to the penis. EDSWT is a non-invasive treatment that requires no drugs and can potentially offer long-term benefits. This same method has been successfully tested and regularly used in other areas of medicine including Orthopedics, Aesthetic Medicine, and Sports Medicine. The aim of EDSWT is to trigger regeneration of blood vessel in the penile shaft to support stronger, longer, and more satisfying erections.

PRP Therapy – Platelet Rich Plasma Injections

Using the patient’s blood, platelet rich plasma is separated and injected into the penis, with the goal of revitalizing muscles and tissues and improving circulatory function. PRP Shot injections are safe and approved by Health Canada.
Plasma-rich-platelet therapy (PRP) has also been a successful treatment modality in orthopedics, plastic surgery, and sports medicine.

Testosterone Replacement Therapy (TRT)

TRT is a hormone replacement therapy that can counter the effects of low testosterone production. TRT can help men with low testosterone regain sexual function (including quality of erections), support overall health and energy levels, as well as mood and mental function.

At Pollock Clinics the goal is to carefully select patients with erectile dysfunction who may also have signs and symptoms of low testosterone through detailed history taking, focused physical examination, and proper biochemical laboratory findings to determine the appropriateness of TRT.

Your ED Treatment Centre in Vancouver

Sexual wellness is essential to your health and happiness and should continue to be as you age. Many scientific studies have shown the numerous benefits of a healthy and active love-life which include: living longer, greater well-being and a happier and longer lasting relationship with your partner.

Dr. Neil Pollock
Pollock Clinics
+1 604-717-6200
email us here


Source: EIN Presswire

Bedford Massachusetts Drug Delivery Company Integral BioSystems Announces New Zealand Patent Grant on OcuSurf™ Invention

Specialty drug delivery company Integral BioSystems LLC has won a broad patent allowance by the IPONZ for its platform delivery innovation OcuSurf™

OcuSurf™ presents new opportunities for developing new and improved drug products”

— Dr. Shikha Barman

BEDFORD, MASSACHUSETTS, US, January 18, 2019 /EINPresswire.com/ — Boston-area hybrid CRO/innovation company Integral BioSystems, has won a patent allowance from the Intellectual Property Office of New Zealand on one of its flagship inventions, OcuSurf™, a novel, patented, differentiated and improved formulation approach for medications to treat disorders of the ocular surface and the anterior chamber of the eye. Products formulated in OcuSurf™ are highly bioavailable and tissue-permeating, due to its ability to rapidly absorb into tissue. OcuSurf™ variants for other routes such as oral, dermal, rectal, and urology have been enabled with multiple small-molecule drugs. Due to the high tissue permeation enabled by OcuSurf™, this innovation is an excellent 505b2 strategy for drug reformulation, either to bridge the revenue gap for patent-expired products or to offer a path to render insoluble, impermeable drugs bioavailable.

The Details
A substantial number of ophthalmic drug products for disorders of the ocular surface are hydrophobic, or sparingly soluble in water, and formulated as suspensions. This results in less than 5% of each eye-drop actually being absorbed by the target tissue. Such formulations typically contain a high concentration of drug to achieve a therapeutic effect. OcuSurf™ nanostructured emulsions are formulated into mucosa-penetrating, tissue absorbed nanoparticles, melting at body temperature to release dissolved drug at the requisite tissue site, allowing much less drug to be administered for equivalent or better therapeutic effect.

Integral BioSystems is developing an ophthalmic pipeline utilizing this technology. As a business strategy, Integral invites licensing-based collaborations for other potential applications in ophthalmic, dermal or other routes that can benefit from this technology.

About Integral BioSystems
Since its formation in 2011, Integral BioSystems has established credibility in drug formulation, CMC consulting, analytical method development and methods qualification, as well as scale-up process engineering. Along with its strong presence as an ophthalmic product development CRO, the company also has expertise in other routes, including injectables, infusions, topical dermal gels/creams, and nanocrystals. Integral BioSystems provides expertise and know-how in developing both front-of-the-eye and back-of-the-eye products, offering complete development services in pre-formulation, including bioanalytical.

For companies seeking to develop a new product that is using a re-purposed drug, Integral offers its innovative delivery systems as licensable technologies to build value into prospective clients’ drug products through a 505b2 regulatory strategy. For companies seeking product life cycle management, Integral can help them quickly ascertain if Integral’s innovations can provide the desired improvements. With multiple billion dollar drug products going off-patent, this presents a cost effective way to develop an extended product life cycle with novel IP. In this manner, Integral will offer its insight and technological innovations in drug delivery to strategize and improve the customer’s product portfolio. To this effect, Integral BioSystems has been a development partner for both innovative and generic companies.

Dave Karasic
Integral BioSystems, LLC
617-820-8483
email us here


Source: EIN Presswire

LATITUDE Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Stabilized Aqueous Glucagon Formulations

Patent Application Covers Glucagon Formulations for Use with Insulin Pumps and Artificial Pancreas

SAN DIEGO, CA, US, January 17, 2019 /EINPresswire.com/ — LATITUDE Pharmaceuticals Inc., a specialized formulation developer for the biotech and pharma industries, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) related to its patent application covering a stabilized soluble glucagon formulation (“Pumpagon”). Thus, a USPTO patent examiner has determined that LATITUDE’s Pumpagon formulation is entitled to a patent under US patent law. Other Pumpagon-related international patent applications are pending.

“We are highly pleased the USPTO has recognized the novelty and industrial utility of our simple and inexpensive approach for keeping glucagon solubilized and stable in an aqueous pumpable solution,” noted Andrew X. Chen, LATITUDE’s President. “Since Pumpagon is more stable than presently marketed glucagon formulations and because it does not contain any new, irritating or unapproved ingredients, our formulation could have a very short development path to become the glucagon formulation of choice for use with the dual hormone insulin/glucagon pumps (artificial pancreas), as well as for mini-dose glucagon administration to treat children with Type 1 diabetes, two emerging diabetes therapies that will be enabled by the multi-day stable Pumpagon.”

About Pumpagon
LATITUDE’s Pumpagon can be prepared using common approved injectable ingredients or by combining a marketed dextrose solution and a lyophilized glucagon, which are both FDA-approved and have decades of proven clinical safety. Given the extensive familiarity and proven safety of its components, Pumpagon may have immediate utility for a greatly accelerated FDA approval process for use in treating diabetes.

About LATITUDE Pharmaceuticals Inc.
LATITUDE is a developer of innovative drug formulations and drug delivery systems for the biotech and pharmaceutical industries. The company is highly regarded for its intellectual property-generating and innovative approaches to developing pharmaceutical formulations for problematic and/or highly insoluble drug molecules.

For more information, please contact:
Matthew A. Singer, PhD
VP, Head of Business Development
Tel: 858-546-0924, ext. 103
Email: matthewsinger@latitudepharma.com

Matthew Singer
LATITUDE Pharmaceuticals Inc.
+1 8585460924
email us here
Visit us on social media:
LinkedIn


Source: EIN Presswire

Invitation from Roderick E. Hubbard at Vernalis Research chairing SMi’s Drug Discovery Conference

Event Chairman Roderick Hubbard from Vernalis personally invites you The 3rd Annual Drug Discovery Chemistry Conference, which is proudly sponsored by Selvita.

LONDON, LONDON, UNITED KINGDOM, January 17, 2019 /EINPresswire.com/ — The two-day conference is returning to London, UK this year on the 18th and 19th March and aims to look beyond to the next generation of enabling tools and technologies enabling a more rational, fast and successful drug discovery.

Roderick E. Hubbard; Professor, University of York and Senior Fellow, Vernalis Research. Vernalis Research is based in Cambridge in the UK that focuses on developing and applying fragment and structure-based methods to solve problems in drug discovery.
Professor Hubbard has been an academic at York for over 35 years working with methods for analysis and exploitation of protein structure. Since 2001 he has split his time between Vernalis and York (fragment methods for chemical biology and industrial biotechnology). In addition, he works with UK Research Councils and consults with pharmaceutical and technology companies around the world.

On his personal invitation he mentions:
“The drug discovery field continues to undergo rapid change in response to the increased pressures of developing new therapies, reducing costs and avoiding late stage drug failure. As an industry, we continue to look for innovative methods to provide access to new target classes and to speed up and improve the drug discovery process. Although these new methods always sound compelling, it always takes some time and experience to realise their potential.

This Drug Discovery Chemistry Conference will feature presentations from scientists with expertise in many of the emerging methods and disciplines:
• Opportunities and applications for AI across the drug discovery process
• Hit ID –encoded libraries, fragments, PROTACs, macrocycles, antibodies
• Optimising the process and enabling drug discovery for challenging targets

PLUS you can also attend the post-conference workshop (20th March 2019) on Artificial Intelligence in Drug Discovery, which is led by Dr Nick Camp, Drug Discovery Consultant at Nick Camp Consulting Ltd

You can visit the website and download the brochure from the website at: http://www.drug-discovery.co.uk/PR3

Should you wish to join us the conference and/or workshop, you can register your place at http://www.drug-discovery.co.uk/PR3 and save £100 expires this month.

For sponsorship opportunities please contact Alia Malick, Director on +44 (0) 20 7827 6168 or email amalick@smi-online.co.uk.

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

Drug Discovery Chemistry
Conference: 18th & 19th March 2019
Half-day post-conference workshop: 20th March 2019 – 8:30am to 12:30pm
Copthorne Tara Hotel, London, UK
http://www.drug-discovery.co.uk/PR3
Follow us @SMiPharm on Twitter
#SMiDrugDischem

—- END —-
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
+1 2078276000
email us here


Source: EIN Presswire

Hearing Health Foundation Welcomes Margo Amgott as Interim CEO

Hearing Health Foundation (HHF) is pleased to begin the New Year with the guidance of Margo Amgott as Interim Chief Executive Officer.

As we continue to nurture cutting-edge research, the Board and I are confident Margo will be an asset during this time of transition.”

— Board Chair Elizabeth Keithley, Ph.D.

NEW YORK, NY, UNITED STATES, January 17, 2019 /EINPresswire.com/ — Hearing Health Foundation (HHF), the largest nonprofit funder of hearing and balance research in the U.S. is pleased to begin the New Year with the guidance of Margo Amgott as Interim Chief Executive Officer, succeeding Nadine Dehgan’s dedicated service to the foundation. Margo will lead HHF overseeing operations and working with the Board on a search for a permanent replacement.

“I am excited to work with HHF’s committed Board of Directors and talented staff to foster support for groundbreaking hearing and balance research,” said Margo, who will champion the start of HHF’s seventh decade of advancing scientific knowledge of hearing loss. HHF has funded research leading to the development of cochlear implant technology and biological hearing restoration in mammals. She added that she is “thrilled to be a part of this vibrant organization supporting life-changing discoveries.”

Board Chair Elizabeth Keithley, Ph.D., remarks, “HHF is delighted to partner with Margo as we continue to nurture cutting-edge research. The Board and I are confident she will be an asset during this time of transition overseeing our operations and helping us to identify the next leader for our dynamic organization.”

With 30 years of nonprofit leadership experience, Ms. Amgott’s professional history includes service to academic medical centers, higher education institutions, government agencies, and healthcare and community nonprofits. Earlier in her career, she directed New York City’s Early Intervention Program and also served as Executive Director of the NYU Child Study Center. She holds a masters degree in health policy and management from NYU’s Wagner Graduate School of Public Administration and a BA in anthropology from Barnard College.

Margo also shares a deeply personal connection with HHF. In 2014, she was diagnosed with a mild unexplained hearing loss and tinnitus in her left ear.

“I welcome the opportunity to work with HHF because of its mission to improve the quality of life for nearly 50 million Americans,” Ms. Amgott says. “I am learning professionally―and personally―from the work HHF does every day. The partnership between our remarkable scientists and our generous supporters has made demonstrable progress towards prevention and cure, and like so many others, I look forward to these vital discoveries.”

Hearing Health Foundation (HHF) exists to better the lives of people with hearing loss, tinnitus, and related conditions. HHF is the nation's largest nonprofit funder of hearing loss research and has awarded more than $50 MM to scientists performing groundbreaking work since its establishment in 1958. Learn more at www.hhf.org.

Lauren McGrath
Hearing Health Foundation
+1 212-257-6146
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Pavel Rombakh Discusses the Challenger Explosion

Pavel Rombakh

Pavel Rombakh

What exactly happened during the Challenger Spacecraft explosion? Researcher Pavel Rombakh discusses the Challenger accident and theories.

EDMONDS, WASHINGTON, UNITED STATES, January 17, 2019 /EINPresswire.com/ — On the morning of January 28, 1986, the NASA shuttle orbiter mission STS-51-L and the tenth flight of the Space Shuttle Challenger, (OV-99) broke apart after just 73 seconds in flight, resulting in the untimely death of all seven crew members, consisting of five NASA astronauts, and two payload specialists.

After breaking apart, the spacecraft disintegrated over parts of the Atlantic ocean, and also off the coast of Cape Canaveral, Florida.

When thinking about this accident, it’s important to discuss Richard Feynman, a theoretical physicist and one of the authors of quantum electrodynamics, an explanation of the modern physical theory.

Because of Feynman's theory, we now understand how natural law and man-made disasters connect together. When natural law is ignored, these types of tragedies occur.

“The fact that this danger did not lead to a catastrophe before is no guarantee that it will not the next time, unless it is completely understood,” Feynman went on to explain. “When playing Russian roulette, the fact that the first shot got off safely is little comfort for the next.”

“Feynman was able to uncover that a rubber seal on the rocket cracked and gas was able to flow out and ignited the explosion,” explained Pavel Rombakh. “This lead to one of the greatest accidents in American history.”

The vehicle began breaking apart after a joint in the right solid rocket booster failed at liftoff. This failure was ultimately caused by the O-ring seals malfunctioning as they were not designed to handle the unusually cold conditions with this specific launch. Because of this failure in the seal, a breach was caused, allowing pressurized burning gas from within the solid rocket motor to get outside and affect other joint attachment hardware, including the external fuel tank, leading to the separation of the solid rocket motors aft field joint attachment. This ultimately led to the structural failure of the external gas tank, with aerodynamic forces breaking up the spacecraft.

Because of the negligence of this accident, the disaster resulted in a 32-month long shutdown of the shuttle programs and the formation of a commission to uncover the truth, entitled Rogers, a special Commission about by President Ronald Reagan.

“The Commission ultimately found NASA to have an organizational culture and decision-making process problem that had been a key factor to the accident,” explained Pavel Rombakh. "Ultimately NASA had violated their own safety protocols.”

Since the late 1970’s NASA managers had known about the potential flaws inside of the SRB rocket and the o-rings but had never truly addressed the problem to correct it, and they also did not listen to multiple warnings from engineers about launching on that day with the drastically low temperatures.

“Because of the Rogers Commission and the work of Feynman, much research has been done to make sure accidents like this never happen again," explained Pavel Rombakh. “Studies on the Challenger disaster continue to this very day.”

To learn more about the work of Pavel Rombakh, and to connect, click here.

Bryan Powers
Web Presence, LLC
+19413758866
email us here


Source: EIN Presswire

First-in-class antibiotic is safe in rats

PERTH, WESTERN AUSTRALIA, AUSTRALIA, January 17, 2019 /EINPresswire.com/ — A scientific paper published in the journal, Scientific Reports, has shown Ramizol® a first-in-class stilbene-based investigational antibiotic for the treatment of CDI is safe in rats. The objective of the study was to evaluate the potential general toxicity in male and female rats that may arise from repeated exposure of Ramizol® for 14 days at doses of 50 mg/kg, 500 mg/kg and 1500 mg/kg administered orally.

The research, which was undertaken jointly by Boulos & Cooper Pharmaceuticals, US-based Product Safety Labs and ToxStrategies Inc., and Flinders University, has shown no mortalities in this study and no-Ramizol®-related clinical observations or side-effects. Additionally, there were no changes in mean body weight, body weight gain, food consumption or food efficiency in male and female rats attributed to the intake of the drug.

Chief Executive Officer of Boulos & Cooper Pharmaceuticals, Dr Ramiz Boulos, said "We are extremely pleased with these results for two reason. Firstly, we were able to dose rats at a very high dose, equivalent to 150 mg/mL. This level of solubility provides Ramizol® with an edge over its competition where solubility does not limit the need to administer high doses to target drug resistant bacteria. Secondly, the high level of tolerance of Ramizol® in rats has de-risked the development of this asset significantly for our first-in-man clinical trials and has given us the confidence to pursue its development”.

Ramiz Boulos
Boulos & Cooper Pharmaceuticals Pty Ltd
+61 431 150 538
email us here
Visit us on social media:
LinkedIn


Source: EIN Presswire

Boat Harassment Concerns for Victorian Dolphins

Vessel approaching closer than 100 metres

Reports of vessels harassing dolphins raise concern for their welfare following reports about vessels harassing dolphins in both Port Phillip & Western Port.

“We must respect them by obeying the marine mammal regulations”, said Jeff Weir. “It’s not about spoiling the remarkable experience of seeing dolphins, just showing common sense”.

— Jeff Weir

MELBOURNE, VIC, AUSTRALIA, January 17, 2019 /EINPresswire.com/ — Boat Harassment Concerns for Victorian Dolphins
Reports of vessels harassing dolphins in both our bays raise concern for their welfare.
The Dolphin Research Institute has been inundated directly and through social media, about vessels harassing dolphins in both Port Phillip and Western Port.
TV news even screened a “fluff piece” showing people doing the wrong thing in Port Phillip.
This also comes in a week where Wildlife Officers are investigating the alleged stabbing of a dolphin in Gippsland.
Our bays are home to resident communities of bottlenose dolphins and common dolphins that share their home with 5 million Melburnians.
“It is remarkable to have these dolphins living in our backyard, when many coastal communities around the world (and Australia) are at risk of losing their resident dolphins”, said Jeff Weir.
“We must respect them by obeying the marine mammal regulations”, said Weir. “It’s not about spoiling the remarkable experience of seeing dolphins, just showing common sense”.
Victoria’s regulations state that “People shouldn’t deliberately approach dolphins closer than 100 metres in boats, 300 metres on Jetskis or 30m for paddlers and swimmers”.
If dolphins pop up close to you or approach your vessel, then ideally stop if safe to do so and watch, or slow down and keep your direction. Enjoy and value our remarkable marine treasures, then let them swim off, without following.
More information about the rules and protecting dolphins are available on the Dolphin Research Institute’s website: www.dolphinresearch.org.au
Everyone can help the Institute’s long-term research programs by reporting dolphin sightings. They can also join people who have supported the Adopt-A-Dolphin program for 27 years! Without community support the Institute’s crucial research and education programs to protect our dolphins and bays will not happen.
To report sightings and support the Institute: dolphinresearch.org.au or 03 5979 7100.
END
MEDIA CONTACT: Jeff Weir. 03 5979 7100 | 0419 356 388 | director@dolphinresearch.org.au
IMAGERY: Photos and vision of dolphins are available.

Jeff Weir
Dolphin Research Institute
+61 419356388
email us here


Source: EIN Presswire

CBMJ Places Super Bowl Ads for Baristas EnrichaRoast CBD Coffee – Marks First Time in History for Marijuana Products

Baristas CBD bags

Baristas CBD bags

Baristas Football

Baristas Football

LoudMouth News America

LoudMouth News America

CBMJ

Front Montgomery NFL

Front Montgomery NFL

CBMJ has successfully placed ads for Baristas EnrichaRoast CBD Coffee at Super Bowl LIII. First time any Marijuana related product will be seen at a Super Bowl.

Canna Consumer Goods, Inc. (OTCMKTS:CBMJ)

This is very significant in the development of cannabis companies gaining access to mainstream media due to CBMJ's unique position in the industry.”

— Darryn Gilliam

WEST PALM BEACH, FL, UNITED STATES, January 16, 2019 /EINPresswire.com/ — Canna Consumer Goods, Inc. / DBA Canna Broadcast Media (OTCPK:CBMJ) has successfully placed ads for Baristas EnrichaRoast CBD Coffee at Super Bowl LIII. The game is scheduled to be played on February 3, 2019 and is the 53rd Super Bowl and the 49th modern-era National Football League championship game. It will decide the league champion for the 2018 NFL season. This year’s game will be played at The Mercedes-Benz Stadium is in Atlanta, Georgia.

This is the first time any Marijuana related product will be seen at a Super Bowl, making this a ground-breaking moment.

The EnrichaRoast CBD ads are only able to be cleared due to Canna Broadcast Medias’ (OTCPK:CBMJ) geofencing platform which will deliver ads in and around the stadium. Canna Broadcast Media specializes in getting mainstream media cleared promoting the cannabis sector including network TV, radio, and digital ads targeting those who wish to take advantage of the incredible investment opportunities that exist in the cannabis sector.

Being at the forefront of building awareness around Cannabis companies is a personal goal of Canna Broadcast Media. Strategic partnerships allow CBMJ to cultivate ROI based on the direction of their clients. With years of advertising and investor relations experience at the foundation of CBMJ, the presences of wisdom will never be doubted.
A partnership with Baristas Coffee Company, one of the most recognized coffee brands in the country, was just signed making CBMJ the exclusive ad placement agency for all Barista marijuana derivative products. So, you can look for ads at this year’s Super Bowl featuring Baristas products, all made possible by CBMJ. The ads will run throughout the day in and around the stadium before, during, and after the game and will include a special offer to send a message to the headlining halftime performer just confirmed to be Maroon 5. The spots will be seen on numerous digital displays including mobile devices allowing fans to connect via a special Baristas EnrichaRoast CBD coffee portal.

CBMJ also owns the popular cannabis news radio program “Loudmouth News”. Originating in Seattle "LoudMouth News" www.loudmouthnews.com became the first and is the longest-running syndicated terrestrial radio news program that focuses on the news relating to the marijuana industry in the USA. Last week this groundbreaking series reached an agreement for LoudMouth News to be heard via syndicated networks across Canada. LoudMouth News presents the news and commentary in an entertaining neutral manner highlighting the most impactful current news in politics, products, sociological issues, businesses, and the ever-changing perceptions of marijuana usage. LoudMouth News is currently cleared to air on over 700 radio stations in the USA, is broadcast by YouTube https://www.youtube.com/channel/UCVUtl_HEsKdZ1uTlnjmgB1Q and now is expanding into Canada.

Canna Broadcast Media also recently acquired the assets, of the Canna Broadcasting Network including its Television Properties, Canna News Group, Digital delivery platform, agreements with Network partners, web-based properties, sales channel, cash, pre-paid TV media, radio media, and projects in development.

Canna Broadcast Media continues to build the first multi-faceted media company devoted to the cannabis industry. Although prohibited from doing so independently, with Canna Broadcast Media, cannabis company’s have access to mainstream media in print, TV, and online, on a National and Canadian basis. Simply put, CBMJ allows them to get marijuana products and companies access to mainstream media in ways that without CBMJ are currently just not possible.

About CBMJ: (CBMJ) dba Canna Broadcast Media specializes in getting mainstream media cleared promoting the cannabis sector including network TV, radio, and digital ads targeting those who wish to take advantage of the incredible investment opportunities that exist in the cannabis sector. Canna Broadcast Media acquired "LoudMouth News" www.loadmouthnews.com which became the first and longest-running syndicated terrestrial radio news program that focused on the news relating to the marijuana industry. LoudMouth News presents the news and commentary in an entertaining neutral manner highlighting the most impactful current news in politics, products, sociological issues, businesses, and the ever-changing perceptions of marijuana usage.

Darryn Gilliam
Canna Consumer Goods, Inc.
+1 425-346-9051
email us here

Baristas Coffee Commercial Megs McLean


Source: EIN Presswire